Using the relative risk from the study of Thorlacius et al. [32], and the estimated prevalence’s of those with and without the mutation of the BRCA2 gene the risks of female breast cancer were calculated, and are shown in Table O in S1 File. This evidence concerns the gene BRCA2 and breast cancer.